These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32618442)

  • 1. Blau Syndrome: NOD2-related systemic autoinflammatory granulomatosis.
    Takada S; Saito MK; Kambe N
    G Ital Dermatol Venereol; 2020 Oct; 155(5):537-541. PubMed ID: 32618442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.
    Matsuda T; Kambe N; Takimoto-Ito R; Ueki Y; Nakamizo S; Saito MK; Takei S; Kanazawa N
    Front Immunol; 2022; 13():895765. PubMed ID: 35711422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.
    Ong LT; Nachbur U; Rowczenio D; Ziegler JB; Fischer E; Lin MW
    Innate Immun; 2017 Oct; 23(7):578-583. PubMed ID: 28836875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.
    Okazaki F; Wakiguchi H; Korenaga Y; Nakamura T; Yasudo H; Uchi S; Yanai R; Asano N; Hoshii Y; Tanabe T; Izawa K; Honda Y; Nishikomori R; Uchida K; Eishi Y; Ohga S; Hasegawa S
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):18. PubMed ID: 33602264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?
    Inoue Y; Kawaguchi Y; Shimojo N; Yamaguchi K; Morita Y; Nakano T; Arima T; Tomiita M; Kohno Y
    Mod Rheumatol; 2013 Jul; 23(4):837-9. PubMed ID: 22821420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blau Syndrome With Delayed Cutaneous Manifestations: A Case Report.
    Panah E; Garfield E; Zahirsha Z; Muhlbauer A; Lake E; Speiser J
    Am J Dermatopathol; 2024 Jun; 46(6):381-382. PubMed ID: 38648024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.
    Okafuji I; Nishikomori R; Kanazawa N; Kambe N; Fujisawa A; Yamazaki S; Saito M; Yoshioka T; Kawai T; Sakai H; Tanizaki H; Heike T; Miyachi Y; Nakahata T
    Arthritis Rheum; 2009 Jan; 60(1):242-50. PubMed ID: 19116920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Pathogenic
    Rodrigues FG; Petrushkin H; Webster AR; Bickerstaff M; Moraitis E; Rowczenio D; Aróstegui JI; Westcott M
    Ophthalmic Genet; 2021 Dec; 42(6):753-764. PubMed ID: 34251956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent stem cell models of Blau syndrome reveal an IFN-γ-dependent inflammatory response in macrophages.
    Takada S; Kambe N; Kawasaki Y; Niwa A; Honda-Ozaki F; Kobayashi K; Osawa M; Nagahashi A; Semi K; Hotta A; Asaka I; Yamada Y; Nishikomori R; Heike T; Matsue H; Nakahata T; Saito MK
    J Allergy Clin Immunol; 2018 Jan; 141(1):339-349.e11. PubMed ID: 28587749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blau syndrome with pulmonary nodule in a child.
    Su J; Liu D
    Australas J Dermatol; 2021 May; 62(2):217-220. PubMed ID: 33742458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blau Syndrome: Challenging Molecular Genetic Diagnostics of Autoinflammatory Disease.
    Brichova M; Klimova A; Heissigerova J; Svozilkova P; Vaneckova M; Dolezalova P; Nemcova D; Michalickova M; Jedlickova J; Dudakova L; Liskova P
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
    Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
    J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
    Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
    Front Immunol; 2022; 13():988862. PubMed ID: 36189261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of symptoms in Blau syndrome/early-onset sarcoidosis following delivery.
    Mizawa M; Makino T; Nakamura T; Yamaguchi S; Taki H; Shimizu T
    Eur J Dermatol; 2015; 25(6):620-2. PubMed ID: 26712281
    [No Abstract]   [Full Text] [Related]  

  • 15. [The present and the prospect of study on Blau syndrome/early-onset sarcoidosis].
    Nakano M; Kambe N
    Nihon Rinsho; 2013 Apr; 71(4):737-41. PubMed ID: 23678609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blau syndrome with a rare mutation in exon 9 of
    Velickovic J; Silan F; Bir FD; Silan C; Albuz B; Ozdemir O
    Autoimmunity; 2019; 52(7-8):256-263. PubMed ID: 31556326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis.
    Zhong Z; Ding J; Su G; Liao W; Gao Y; Zhu Y; Deng Y; Li F; Du L; Gao Y; Yang P
    Ophthalmology; 2022 Jul; 129(7):821-828. PubMed ID: 35314268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the
    Matsuda T; Kambe N; Ueki Y; Kanazawa N; Izawa K; Honda Y; Kawakami A; Takei S; Tonomura K; Inoue M; Kobayashi H; Okafuji I; Sakurai Y; Kato N; Maruyama Y; Inoue Y; Otsubo Y; Makino T; Okada S; Kobayashi I; Yashiro M; Ito S; Fujii H; Kondo Y; Okamoto N; Ito S; Iwata N; Kaneko U; Doi M; Hosokawa J; Ohara O; Saito MK; Nishikomori R; ;
    Ann Rheum Dis; 2020 Nov; 79(11):1492-1499. PubMed ID: 32647028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blau syndrome with NOD2 mutation in a 54-year-old man: A case report.
    Wang Z; Yang M; Zhang Q; Zhang S; Sui H; Liu J; Yang Q
    Int J Rheum Dis; 2023 Oct; 26(10):2080-2084. PubMed ID: 37246600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
    Yao Q
    Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.